Advertisement
WuXi Biologics (Cayman) Inc. (2269.HK)
HKSE - HKSE Delayed Price. Currency in HKD
Follow
At close: 04:08PM HKT
| Previous Close | 16.440 |
| Open | 16.520 |
| Bid | 16.840 x 0 |
| Ask | 16.860 x 0 |
| Day's Range | 16.160 - 17.200 |
| 52 Week Range | 10.140 - 52.450 |
| Volume | |
| Avg. Volume | 80,083,974 |
| Market Cap | 69.197B |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | 25.55 |
| EPS (TTM) | 0.660 |
| Earnings Date | Aug 21, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.99 |
PR NewswireWuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive Year
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has received a Platinum Award from The Asset ESG (Environmental, Social and Governance) Corporate Awards for the fourth year in a row. The prestigious honor recognizes the company's unwavering commitment to sustainable practices as well as its effective approaches to driving innovation and efficiency through green technology.
GuruFocus.comWuXi Biologics (Cayman) Inc (WXXWY) Half Year 2024 Earnings Call Highlights: Navigating Growth ...
Despite a flat overall revenue, WuXi Biologics (Cayman) Inc (WXXWY) shows resilience with strong non-COVID growth and strategic project acquisitions.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.